Tzu Hung Tammy Chen
About Tzu Hung Tammy Chen
Tzu Hung Tammy Chen is a Development Associate III at Sangamo Therapeutics in Brisbane, California. She has a background in Biochemical Science and Biotechnology, with previous research roles at National Taiwan University and Northwestern University.
Work at Sangamo Therapeutics
Tzu Hung Tammy Chen has been employed at Sangamo Therapeutics as a Development Associate III since 2020. In this role, she contributes to the development of innovative therapies, focusing on gene editing and gene therapy technologies. Her position involves collaboration with cross-functional teams to advance projects from the research phase to clinical development, ensuring compliance with regulatory standards.
Education and Expertise
Tzu Hung Tammy Chen earned a Bachelor of Science in Biochemical Science from National Taiwan University, completing her studies from 2009 to 2013. She furthered her education by obtaining a Master of Science in Biotechnology from Northwestern University, where she studied from 2016 to 2018. Her academic background provides a strong foundation in biochemical and biotechnological principles, enhancing her expertise in the field.
Background
Tzu Hung Tammy Chen began her academic career at National Taiwan University, where she worked as an Undergraduate Research Assistant from 2012 to 2013. Following this, she served as a Research Assistant at the same university from 2014 to 2016. In 2017, she interned at Boehringer Ingelheim for three months in Germany. During her graduate studies at Northwestern University, she worked as a Graduate Research Assistant from 2017 to 2018.
Professional Experience
Tzu Hung Tammy Chen has accumulated diverse professional experience in research and development roles. After her tenure as an Undergraduate Research Assistant, she transitioned to a Research Assistant position at National Taiwan University. Her internship at Boehringer Ingelheim provided her with industry exposure, and her role as a Graduate Research Assistant at Northwestern University allowed her to deepen her research skills before joining Sangamo Therapeutics.